Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study

By Mok C. C.   Ho L. Y.   Cheung M. Y.   Yu K. L.   To C. H.  

Scandinavian Journal of Rheumatology, Vol. 38, Iss. 2, 2009-01 ,pp. : 121-127

Informa Healthcare

Access to resources Recommend Favorite

Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity

By Mader Reuven   Mishail Samer   Adawi Muhammed   Lavi Idit   Luboshitzky Rafael  

Clinical Rheumatology, Vol. 26, Iss. 11, 2007-11 ,pp. : 1891-1894

Springer Publishing Company

Access to resources Recommend Favorite

Disease activity and antinucleosome antibodies in systemic lupus erythematosus

By Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 1, 2003-01 ,pp. : 42-45

Informa Healthcare

Access to resources Recommend Favorite

Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy

By Bonilla-Abadía F   Betancurt J   Pineda J   Vélez J   Tobón G   Cañas C  

Clinical Rheumatology, Vol. 33, Iss. 3, 2014-03 ,pp. : 415-418

Springer Publishing Company

Access to resources Recommend Favorite

Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus

By Hassan Adla B.   Lundberg Ingrid E.   Isenberg David   Wahren-Herlenius Marie  

Scandinavian Journal of Rheumatology, Vol. 31, Iss. 3, 2002-05 ,pp. : 133-139

Informa Healthcare

Access to resources Recommend Favorite